The Valley Desk

ReviewNucleic acid therapeuticsPublished

Immunogenicity Risk Assessment for Nucleic Acid Therapeutics: A Comprehensive Evaluation for ASO, siRNA, and Nonvaccine mRNA/LNP Therapies by the IQ Consortium

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK. Affiliation source

Publication record

Type
Review
Venue
Nucleic acid therapeutics
Published
Subject terms
Humans; Lipids; Oligonucleotides, Antisense; RNA, Small Interfering; RNA, Messenger; Liposomes; Risk Assessment; Nanoparticles; Nucleic acid; Oligonucleotide; ASO; SSO
PubMed ID
41204722
Added to directory
Source checked

Report a correction or request removal